Trial Profile
Treatment with a novel peptide, SR-0379, for the Werner syndrome patients with limb ulcers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 May 2018
Price :
$35
*
At a glance
- Drugs SR 0379 (Primary)
- Indications Leg ulcer; Skin ulcer
- Focus Therapeutic Use
- 22 May 2018 Status changed from recruiting to completed.
- 06 Sep 2017 New trial record